Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-11-01
coleção:	BMC Cancer
Assuntos:	Neuroendocrine prostate cancer Small cell carcinoma Mixed prostatic adenocarcinoma FFPE Gene signature Meta-analysis
Acesso em linha:	http://link.springer.com/article/10.1186/s12885-017-3729-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!